North America Is Dominating Recombinant Proteins Market

In 2022, North America led the market, generating a revenue share of approximately 45%, mainly because of the increasing occurrence of communicable and chronic syndromes and supportive government steps. Moreover, the increasing need for these items in the R&D studies conducted by the KEY players is driving the industry in the continent.